Log-order improved in trans hammerhead ribozyme turnover rates: reevaluating therapeutic space for small catalytic RNAs
The paper reports an enhanced hammerhead ribozyme with high turnover rates, comparable to RNase A, suggesting its potential as a druggable RNA therapeutic.
bioRxiv · Apr 26, 2022 · PreprintPharmacology & Toxicology